Company intelligence / Profile preview

Apotea

Ownership: Private
Employees: ~800
Development stage: Other

Overview

Apotea is Sweden’s largest online pharmacy, offering over 24,000 over-the-counter products and nearly 16,000 prescription drugs for humans and animals. The company has grown rapidly since its founding in 2011–2012 to become the leading e-pharmacy in Sweden with more than three million active customers. It focuses on fast delivery, free shipping options, automation-driven logistics (including world-first robot piece-picking integration), and an extensive product range. Apotea went public on Nasdaq Stockholm in December 2024.

Therapeutic areas: NeurologyMetabolic DisordersInfectious DiseasesDermatologyEndocrinologyOtherImmunologyWomen's Health
Modalities: Small moleculeBiologic
Industry: Non-Academic Healthcare

Partnerships

Element Logic (warehouse automation)

Beyond the preview

Go deeper on Apotea.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apotea.

Explore the full profile